A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)
Clinical trial NCT00780039 · COMPLETED
Trial details
- NCT number
- NCT00780039
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2007-09-06
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.